ArticleCancer medicine2022

Anlotinib plus platinum-etoposide as a first-line treatment for extensive-stage small cell lung cancer: A single-arm trial.

Pengbo Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.